MedPath

Growth of Healthy Term Infants Fed a Partially Hydrolyzed Follow-up Formula

Not Applicable
Completed
Conditions
Growth
Registration Number
NCT03276663
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

Growth of healthy term formula-fed infants who receive a single feeding regimen consisting of an existing partially hydrolyzed starter formula, then subsequently fed a partially hydrolyzed follow-up formula over the first year of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
194
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Growth velocity (weight gain in g/day) of healthy term formula-fed infants during the first 6 months6 month

compared to the WHO reference standards or to the human milk (HM)-fed comparator group.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

CHU Amiens Picardie Site SUD

🇫🇷

Amiens, France

CHU Bordeaux - Hôpital Pellegrin Enfants

🇫🇷

Bordeaux, France

CHU de Caen

🇫🇷

Caen, France

CHU Nantes - Hôpital Mère-Enfant

🇫🇷

Nantes, France

Hopital Necker

🇫🇷

Paris, France

Biofortis CIC

🇫🇷

Saint-Herblain, France

CHU Amiens Picardie Site SUD
🇫🇷Amiens, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.